XML 81 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Basic:      
Net income attributable to Edwards Lifesciences Corporation $ 1,402.4 $ 1,521.9 $ 1,503.1
Weighted-average shares outstanding (in shares) 606.7 619.0 623.3
Basic earnings per share (in dollars per share) $ 2.31 $ 2.46 $ 2.41
Diluted:      
Net income attributable to Edwards Lifesciences Corporation $ 1,402.4 $ 1,521.9 $ 1,503.1
Weighted-average shares outstanding (in shares) 606.7 619.0 623.3
Dilutive effect of stock plans (in shares) 2.7 5.2 7.9
Dilutive weighted-average shares outstanding (in shares) 609.4 624.2 631.2
Diluted earnings per share (in dollars per share) $ 2.30 $ 2.44 $ 2.38